Comparison of the clinical expression of retinitis pigmentosa associated with rhodopsin mutations at codon 347 and codon 23

American Journal of Ophthalmology

Volumn 136, Issue 2, 2003, Pages 306-313

  Oh, Kean T ^a   Longmuir, Reid ^b   Oh, Dawn M ^h   Stone, Edwin M ^b   Kopp, Kelly ^b   Brown, Jeremiah ^c   Fishman, Gerald A ^d   Sonkin, Peter ^e   Gehrs, Karen M ^b   Weleber, Richard G ^f,g  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e Retina Vitreous Associates   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g CASEY EYE INSTITUTE   (United States)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

RHODOPSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; ELECTRORETINOGRAPHY; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HUMAN; PERIMETRY; PHENOTYPE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETINITIS PIGMENTOSA; VISUAL FIELD;

EID: 0041848367     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(03)00206-X     Document Type: Article

References (39)

1. Oh K.T., Weleber R.G., Lotery A., et al. Description of a new mutation in rhodopsin, Pro23Ala, and comparison with electroretinographic and clinical characteristics of the Pro23His mutation. Arch Ophthalmol. 118:2000;1269-1276.
2. Dryja T.P. Doyne Lecture. Rhodopsin and autosomal dominant retinitis pigmentosa. Eye. 6:(Pt 1):1992;1-10.
3. Berson E.L. Retinitis pigmentosa. The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 34:1993;1659-1676.
4. Berson E.L. Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect. Trans Am Ophthalmol Soc. 88:1990;355-388.
5. Dryja T.P., McGee T.L., Hahn L.P., et al. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. N Engl J Med. 323:1990;1302-1307.
6. Dryja T.P., Hahn L.B., Cowley G.S., McGee T.L., Berson E.L. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 88:1991;9370-9374.
7. Inglehearn C.F., Tarttelin E.E., Plant C., et al. A linkage survey of 20 dominant retinitis pigmentosa families frequencies of the nine known loci and evidence for further heterogeneity . J Med Genet. 35:1998;1-5.
8. Sung C.H., Schneider B.G., Agaarwal N., Papermaster D.S., Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 88:1991;8840-8844.
9. Sung C.H., Davenport C.M., Hennessey J.C., et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 88:1991;6481-6485.
10. Sung C.H., Davenport C.M., Nathans J. Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. J Biol Chem. 268:1993;26645-26649.
11. Sung, C.W., Tai A.W. Rhodopsin trafficking and its role in retinal dystrophies. Int Rev Cytol. 195:2000;215-267.
12. Berson E.L., Rosner B., Sandberg M.A., et al. Ocular findings in patients with autosomal dominant retinitis pigmentosa and rhodopsin, proline-347-leucine. Am J Ophthalmol. 111:1991;614-623.
13. Berson E.L., Sandberg M.A., Dryja T.P. Autosomal dominant retinitis pigmentosa with rhodopsin, valine-345-methionine. Trans Am Ophthalmol Soc. 89:1991;117-128.
14. Berson E.L. Retinitis pigmentosa. unfolding its mystery. Proc Natl Acad Sci U S A. 93:1996;4526-4528.
15. Bessant D.A., Khaliq S., Hameed A., et al. Severe autosomal dominant retinitis pigmentosa caused by a novel rhodopsin mutation (Ter349Glu). Mutations in brief no. 208. [online] Hum Mutat. 13:1999;83.
16. Dryja T.P., Hahn L.B., Cowley G.S., McGee T.L., Berson E.L. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 88:1991;9370-9374.
17. Dryja T.P., Li T. Molecular genetics of retinitis pigmentosa. Hum Mol Genet. 4:(Spec No):1995;1739-1743.
18. Fujiki K., Hotta Y., Hayakawa M., et al. Point mutations of rhodopsin gene found in Japanese families with autosomal dominant retinitis pigmentosa (ADRP). Jpn J Hum Genet. 37:1992;125-132.
19. Gal A., Artlich A., Ludwig M., et al. Pro-347-Arg mutation of the rhodopsin gene in autosomal dominant retinitis pigmentosa. Genomics. 11:1991;468-470.
20. Macke J.P., Hennessey J.C., Nathans J. Rhodopsin mutation proline347-to-alanine in a family with autosomal dominant retinitis pigmentosa indicates an important role for proline at position 347. Hum Mol Genet. 4:1995;775-776.
21. Rodriguez JA, Gannon AM, Birch DG, Heckenlively JR, Daiger SP. Screening for mutations in rhodopsin and peripherin/RDS in patients with autosomal dominant retinitis pigmentosa. Am J Hum Genet 1994;(Suppl):A239.
22. Marmor M.F. An updated standard for clinical electroretinography. Arch Ophthalmol. 113:1995;1375-1376.
23. Weleber R.G., Tobler W.R. Computerized quantitative analysis of kinetic visual fields. Am J Ophthalmol. 101:1986;461-468.
24. Weleber R.G. The effect of age on human cone and rod Ganzfeld electroretinograms. Invest Ophthalmol Vis Sci. 20:1981;392-399.
25. Sandberg M.A., Weigel-DiFranco C., Dryja T., Berson E.L. Clinical expression correlates with location of rhodopsin mutation in dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 36:1995;1934-1942.
26. Birch D.G., Anderson J.L., Fish G.E. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy. Ophthalmology. 106:1999;258-268.
27. Sandberg M.A., Weigel-DiFranco C., Rosner B., Berson E.L. The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 37:1996;1693-1698.
28. Holopigian K., Greenstein V., Seiple W., Carr R.E. Rates of change differ among measures of visual function in patients with retinitis pigmentosa. Ophthalmology. 103:1996;398-405.
29. Berson E.L., Sandberg M.A., Rosner B., Birch D.G., Hanson A.H. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol. 99:1985;240-251.
30. Iannaccone A., Rispoli E., Vingolo E.M., et al. Correlation between Goldmann perimetry and maximal electroretinogram response in retinitis pigmentosa. Doc Ophthalmol. 90:1995;129-142.
31. Drenser K.A., Timmers A.M., Hauswirth W.W., Lewin A.S. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 39:1998;681-689.
32. Hauswirth W.W., Lewin A.S. Ribozyme uses in retinal gene therapy. Prog Retin Eye Res. 19:2000;689-710.
33. Hauswirth W.W., LaVail M.M., Flannery J.G., Lewin A.S. Ribozyme gene therapy for autosomal dominant retinal disease. Clin Chem Lab Med. 38:2000;147-153.
34. O'Neill B., Millington-Ward S., O'Reilly M., et al. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 41:2000;2863-2866.
35. Shaw L.C., Skold A., Wong F., et al. An allele-specific hammerhead ribozyme gene therapy for a porcine model of autosomal dominant retinitis pigmentosa. Mol Vis. 7:2001;6-13.
36. Buffone G.J., Darlington G.J. Isolation of DNA from biological specimens without extraction with phenol. Clin Chem. 31:1985;164-165.
37. Bassam B.J., Caetano-Anolles G., Gresshoff P.M. Fast and sensitive silver staining of DNA In polyacrylamide gels. Anal Biochem. 196:1991;80-83.
38. Berson E.L., Rosner B., Weigel-DiFranco C., Dryja T.P., Sandberg M.A. Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. Invest Ophthalmol Vis Sci. 43:2002;3027-3036.
39. Sandberg M.A., Rosner B., Weigel-DiFranco C., Dryja T.P., Berson E.L. Retinitis pigmentosa due to dominant rhodopsin mutations Rates of progression correlate with location of affected amino acid . Invest Ophthalmol Vis Sci. 43:(Suppl):2002;3949.